Commercial Pharma Segment in Russia Set for Intense Growth

The commercial segment of the Russian pharmaceutical industry is anticipated to grow at a CAGR of around 24% during 2009-2013, says RNCOS in its latest research study.

Noida, India, February 20, 2010 --( According to their latest research report, “Russian Pharma Sector Forecast to 2013”, the commercial segment of the pharma industry in Russia has been continuously witnessing healthy growth rates despite the growing concerns over inflation with respect to drugs, amid recession. Future of the pharma market also remains pleasantly optimistic and a CAGR of around 23% is projected to be achieved by the market during 2009-2013.

They have done extensive research and prudent analysis of the Russian pharma market in order to understand the factors that will continue to serve as the growth drivers for the pharma market in Russia over the forecast period. They have identified that various factors such as growing healthcare spending and increased private investments have been resulting into the increasing usage of high-priced drugs in the country. The report also gives insight into the role of government in the rapid growth of Russian pharma market. Besides this, various other factors propelling the growth of the commercial segment of the pharma industry in the country have been thoroughly evaluated in the report.

Their research indicates that the Russian market is in the initial stages of development and has immense potential of growth in future. The country is highly dependent on imported drugs, thereby giving room to private players to set up their own manufacturing capacities in the country. It also gives an overview of the factors that may hinder the growth of pharma market in Russia in the coming years.

Besides this, their report “Russian Pharma Sector Forecast to 2013” provides an extensive research and rational analysis along with reliable statistics of the Russian pharma sector, thereby presenting a clear picture of the country’s healthcare and pharmaceutical market. It covers leading drugs, segment-wise break up, and information on major therapy areas to give strategic insight into the market. The report thoroughly examines current market trends, industrial developments and competitive landscape to enable clients better understand the market structure and its progress in coming years. Forecast in this research has been done considering the possible post-recession impact on the industry.

For Free Sample of this report visit:

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Shushmul Maheshwari
Chief Executive
B-129, Sector 6 Noida - 201301